Fennec Pharmaceuticals Inc (NASDAQ: FENC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $13.00 price target on the stock.
Fennec Pharmaceuticals Inc (NASDAQ: FENC) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $13.00 price target on the stock.
Investing in Fennec Pharmaceuticals (NASDAQ:FENC) five years ago would have delivered you a 38% gain [Yahoo! Finance]
Fennec Pharmaceuticals Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update
Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2024 Financial Results on March 10, 2025